本發(fā)明涉及一種酸脅迫抗性提高的畢赤酵母,屬于生物工程技術(shù)領(lǐng)域。
背景技術(shù):
在利用有機(jī)酸生產(chǎn)菌株,發(fā)酵生產(chǎn)有機(jī)酸的過程中,隨著有機(jī)酸的積累,胞外pH不斷下降,有機(jī)酸的解離度也持續(xù)下降從而以未解離態(tài)進(jìn)入細(xì)胞。細(xì)胞質(zhì)中較高的pH使得有機(jī)酸解離,釋放出質(zhì)子不斷積累,最終導(dǎo)致細(xì)胞質(zhì)酸化并影響細(xì)胞代謝的代謝和生長(zhǎng)從而影響發(fā)酵過程。在工業(yè)生產(chǎn)中,通常加入大量NaOH、CaCO3等中和劑以維持培養(yǎng)基的pH穩(wěn)定。但中和劑的添加也導(dǎo)致了發(fā)酵液的滲透壓升高和后期產(chǎn)物純化成本增加。因此提高微生物的有機(jī)酸耐受性是提高產(chǎn)量的途徑之一。
畢赤酵母具有表達(dá)蛋白易于純化,產(chǎn)量高等優(yōu)點(diǎn),因此使用較為廣泛。但是畢赤酵母對(duì)酸脅迫的耐受能力較差,不利于研究畢赤酵母作為發(fā)酵產(chǎn)酸菌株。
技術(shù)實(shí)現(xiàn)要素:
為了克服上述問題,本發(fā)明提供了一種提高畢赤酵母酸脅迫抗性的方法,所述方法是以Pichia pastoris GS115為宿主、pPICZα為載體表達(dá)干酪乳桿菌來源的精氨酰琥珀酸裂解酶ArgH。
在一種實(shí)施方式中,所述ArgH的氨基酸序列是SEQ ID NO.1或者SEQ ID NO.2所示的序列。
本發(fā)明的第二個(gè)目的是提供了一種酸脅迫抗性提高的畢赤酵母基因工程菌,所述畢赤酵母基因工程菌以Pichia pastoris GS115為宿主、pPICZα為載體表達(dá)干酪乳桿菌來源的精氨酰琥珀酸裂解酶ArgH。
在一種實(shí)施方式中,所述畢赤酵母基因工程菌的構(gòu)建方法,如下:
(1)通過PCR方法或者化學(xué)合成的方法獲得精氨酰琥珀酸裂解酶基因;
(2)將步驟(1)獲得的精氨酰琥珀酸裂解酶基因連接到畢赤酵母表達(dá)載體pPICZα上,得到重組質(zhì)粒pPICZα-ArgH;
(3)將步驟(2)獲得的重組質(zhì)粒pPICZα-ArgH電轉(zhuǎn)入Pichiapastoris GS115得到表達(dá)精氨酰琥珀酸裂解酶的基因工程菌株。
本發(fā)明的有益效果:
(1)本發(fā)明通過表達(dá)原核來源的精氨酰琥珀酸裂解酶基因,有效提高了真核微生物的酸脅迫抗性。
(2)本發(fā)明還優(yōu)化了精氨酰琥珀酸裂解酶的氨基酸序列,發(fā)現(xiàn)優(yōu)化后的序列能夠更高幅度地提高畢赤酵母的耐酸水平。
具體實(shí)施方式
BMGY培養(yǎng)基(g/L):酵母粉10g,胰蛋白胨20g,甘油20g,(NH4)2SO410g,YNB 3.4g,1moL/L KH2PO4-K2HPO4緩沖液(pH6.0)100mL,生物素4×10-5g;
BMMY培養(yǎng)基(g/L):酵母粉10g,胰蛋白胨20g,(NH4)2SO410g,YNB 3.4g,1moL/L KH2PO4-K2HPO4緩沖液(pH6.0)100mL,生物素4×10-5g。
實(shí)施例1:重組菌的構(gòu)建
(1)重組質(zhì)粒pMD19-T-ArgH的構(gòu)建
采用化學(xué)合成或者PCR的方法,得到含有編碼氨基酸序列為SEQ ID NO.1或者SEQ ID NO.2的基因片段,然后將基因片段連接到pMD19-T質(zhì)粒上,并轉(zhuǎn)化大腸桿菌,驗(yàn)證正確的轉(zhuǎn)化子,得到重組質(zhì)粒pMD19-T-ArgH。抽提pMD19-T-ArgH和pPICZα質(zhì)粒,然后雙酶且pMD19-T-ArgH和pPICZα質(zhì)粒4h,0.7%瓊脂糖凝膠電泳分析。利用割膠回收試劑盒回收目的片段,16℃連接4h后,利用化學(xué)轉(zhuǎn)化法,轉(zhuǎn)化大腸桿菌DH5α。篩選正確的轉(zhuǎn)化子,得到重組質(zhì)粒pPICZα-ArgH。
(2)畢赤酵母基因工程菌的構(gòu)建
以SacI線性化的表達(dá)載體pPICZα-ArgH電轉(zhuǎn)化Pichiapastoris GS115。將驗(yàn)證正確的菌株保種,得到畢赤酵母基因工程菌Pichiapastoris GS115-pPICZα-ArgH。
其中酵母感受態(tài)的制備方法如下:
(a)從新鮮YPD平板上挑取畢赤酵母菌落于25mL YPD液體培養(yǎng)基中,30℃,200r/min培養(yǎng)20h;
(b)將0.5mL上述培養(yǎng)液轉(zhuǎn)接到25mL YPD液體培養(yǎng)基中,30℃,200r/min培養(yǎng)8h(大約OD600=1.3-1.5);
(c)吸取1mL上述菌液于1.5mL無菌的EP管中,4000r/min離心2min,收集菌體,用1.5mL預(yù)冷的無菌水,吹打懸浮細(xì)胞;
(d)4000r/min離心2min,收集菌體,用1mL預(yù)冷的無菌水重新懸浮細(xì)胞;
(e)4000r/min離心2min,收集菌體,用1.5mL預(yù)冷的1moL/L山梨醇懸浮細(xì)胞;
(f)4000r/min離心2min,收集菌體,用100μL預(yù)冷的1moL/L山梨醇混勻細(xì)胞,5min后方可使用。
電穿孔轉(zhuǎn)化法如下:
(I)提前預(yù)熱電穿孔儀;
(II)取80μL酵母感受態(tài)細(xì)胞與20μL線性化的表達(dá)載體,輕輕混勻,冰浴5min;后轉(zhuǎn)入預(yù)冷的0.2cm電擊杯中;
(III)將電擊杯外水汽徹底擦干凈,放入電擊室;
(IV)按電轉(zhuǎn)參數(shù):1.5kV,25μF,200,5ms進(jìn)行電擊;
(V)電擊后立即加入1mL預(yù)冷的1moL/L山梨醇于電擊杯中,輕輕吹打后,將內(nèi)容物全部轉(zhuǎn)入無菌的1.5mL EP管中,于30℃復(fù)活培養(yǎng)1h;
(VI)4000r/min離心5min,去除750μL上清液,將剩余的菌液涂布到含有100μg/mL zeocin的YPDS平板上,30℃培養(yǎng)3-5d。
按照上述方法,得到了2株畢赤酵母基因工程菌Pichiapastoris GS115-pPICZα-ArgH1(表達(dá)氨基酸序列如SEQ ID NO.1的酶)、Pichiapastoris GS115-pPICZα-ArgH2(表達(dá)氨基酸序列如SEQ ID NO.2的酶)。
實(shí)施例2 ArgH蛋白的誘導(dǎo)表達(dá)與檢測(cè)
(a)將實(shí)施例1得到的2株畢赤酵母工程菌分別取單菌落接種于50mL生長(zhǎng)培養(yǎng)基BMGY/500mL三角瓶中,30℃,200r/min培養(yǎng)20h;
(b)將上述BMGY生長(zhǎng)培養(yǎng)基中的菌液,室溫靜置1h,棄掉上清液,用30mL BMMY培養(yǎng)基重新懸浮菌體,加入100%甲醇至終濃度為1%(v/v),30℃,200r/min培養(yǎng),每隔24h補(bǔ)加100%甲醇至終濃度為1%(v/v)進(jìn)行誘導(dǎo)48h。
并用SDS-PAGE蛋白電泳檢測(cè)畢赤酵母工程菌中ArgH蛋白得到表達(dá)。
實(shí)施例3酸脅迫下生長(zhǎng)性能試驗(yàn)
對(duì)于考察菌株在脅迫條件下的生長(zhǎng)情況,將畢赤酵母基因工程菌Pichia pastoris GS115-pPICZα-ArgH1、Pichia pastoris GS115-pPICZα-ArgH2接種于BMGY生長(zhǎng)培養(yǎng)基中的菌液,室溫靜置1h,棄掉上清液,用30mL BMMY培養(yǎng)基重新懸浮菌體,加入100%甲醇至終濃度為1%(v/v),30℃,200r/min培養(yǎng),誘導(dǎo)12h。
然后將誘導(dǎo)后的菌株接種至新鮮的BMMY培養(yǎng)基中,其中BMMY培養(yǎng)基用乳酸調(diào)節(jié)至pH 5.0。分別測(cè)定Pichiapastoris GS115-pPICZα-ArgH1、Pichiapastoris GS115-pPICZα-ArgH2在脅迫條件下的生長(zhǎng)性能,以不表達(dá)外源基因的Pichiapastoris GS115-pPICZα為對(duì)照。
結(jié)果顯示,經(jīng)生長(zhǎng)性能試驗(yàn)分析,Pichiapastoris GS115-pPICZα-ArgH1菌株相對(duì)于Pichia pastoris GS115-pPICZα生物量有約48%的提高,Pichia pastoris GS115-pPICZα-ArgH2菌株相對(duì)于Pichiapastoris GS115-pPICZα生物量有約21%的提高,說明在Pichiapastoris GS115中表達(dá)了ArgH蛋白后,菌株耐酸性顯著提高。
實(shí)施例4酸脅迫條件下耐受性試驗(yàn)
對(duì)于考察菌株對(duì)酸的耐受性分析試驗(yàn),分別測(cè)定了畢赤酵母基因工程菌Pichia pastoris GS115-pPICZα-ArgH1、Pichiapastoris GS115-pPICZα-ArgH2和對(duì)照菌株在pH 4.5條件下的存活率。
具體操作方式如下:將菌株誘導(dǎo)培養(yǎng)至OD 2.0,離心收集細(xì)胞,經(jīng)0.85%的生理鹽水洗滌兩次后重懸于等體積的新鮮的pH 4.5(乳酸調(diào)節(jié))的BMMY中,脅迫不同時(shí)間。脅迫后的菌懸液洗滌兩次后重懸于等體積生理鹽水中,取10μL重懸液,稀釋不同梯度點(diǎn)種于BMMY平板上測(cè)定活菌數(shù)和存活率。
經(jīng)耐受性實(shí)驗(yàn)分析,在pH 4.5的BMMY中脅迫6h后,Pichia pastoris GS115-pPICZα-ArgH1、Pichiapastoris GS115-pPICZα-ArgH2的存活率分別是對(duì)照菌株的2.56倍、1.49倍,說明畢赤酵母基因工程菌對(duì)酸脅迫的耐受性顯著提高。
雖然本發(fā)明已以較佳實(shí)施例公開如上,但其并非用以限定本發(fā)明,任何熟悉此技術(shù)的人,在不脫離本發(fā)明的精神和范圍內(nèi),都可做各種的改動(dòng)與修飾,因此本發(fā)明的保護(hù)范圍應(yīng)該以權(quán)利要求書所界定的為準(zhǔn)。
<110> 吳銀娣
<120> 一種酸脅迫抗性提高的畢赤酵母
<160> 2
<170> PatentIn version 3.3
<210> 1
<211> 467
<212> PRT
<213> 人工序列
<400> 1
Met Gly Thr Ala Gly Met His Met Thr Asp Lys Leu Trp Gly Gly Arg
1 5 10 15
Phe Thr Glu Lys Ala Ala His Trp Val Asp Ala Phe Gly Ala Ser Ile
20 25 30
Gly Phe Asp Gln Gln Met Ala Ser Glu Asp Leu Glu Gly Ser Leu Ala
35 40 45
His Val Lys Met Leu Gly Lys Thr Gly Ile Ile Pro Gln Ala Asp Ala
50 55 60
Asp Thr Ile Thr Ala Gly Leu Gln His Leu Gln Lys Glu Leu Ala Ser
65 70 75 80
Gly Lys Leu His Phe Thr Val Glu Asn Glu Asp Ile His Leu Asn Met
85 90 95
Glu Ala Leu Leu Thr Ala Glu Ile Gly Pro Val Ala Gly Lys Leu His
100 105 110
Thr Ala Arg Ser Arg Asn Asp Gln Val Ala Thr Asp Leu His Leu Trp
115 120 125
Leu Lys His Arg Leu Pro Thr Ile Lys Glu Ala Leu Thr Asn Leu Gln
130 135 140
Thr Val Leu Val Gly Gln Ala Lys Val His Ala Ala Thr Ile Met Pro
145 150 155 160
Gly Tyr Thr His Met Gln His Ala Gln Pro Ile Thr Tyr Gly His Tyr
165 170 175
Leu Leu Ala Tyr Phe Glu Met Phe Gln Arg Asp Trp Glu Arg Phe Asp
180 185 190
Phe Thr Gln Lys His Thr Asp Ile Leu Pro Leu Gly Ala Ala Ala Leu
195 200 205
Ala Gly Thr Thr Phe Pro Ile Asp Arg Thr Leu Val Ala Gln Glu Leu
210 215 220
Gly Phe Asp Gln Ile Tyr His Asn Ser Leu Asp Ala Val Ser Asp Arg
225 230 235 240
Asp Phe Ala Leu Glu Phe Leu Ser Asn Ser Ala Ile Leu Met Gln His
245 250 255
Leu Ser Arg Met Ala Glu Glu Leu Ile Leu Trp Ser Thr Tyr Glu Phe
260 265 270
Asn Tyr Ile Glu Leu Gly Asp Asp Phe Ser Thr Gly Ser Ser Ile Met
275 280 285
Pro Gln Lys Lys Asn Pro Asp Phe Ala Glu Leu Ile Arg Gly Lys Thr
290 295 300
Gly Arg Val Tyr Gly Ala Leu Met Gly Leu Leu Thr Thr Met Lys Ala
305 310 315 320
Ile Pro Leu Ala Tyr Asn Lys Asp Met Gln Glu Asp Lys Glu Pro Ile
325 330 335
Phe Asp Ala Tyr Asn Thr Ile Leu Gly Ser Leu His Ile Phe Thr Gly
340 345 350
Met Leu Ser Asp Leu Thr Val His Glu Lys Arg Met Ala Glu Ala Thr
355 360 365
Thr His Asp Phe Ser Asn Ala Thr Glu Leu Ala Asp Tyr Leu Ala Thr
370 375 380
Lys Gly Val Pro Phe Arg Gln Ala His Ala Ile Val Gly Glu Leu Val
385 390 395 400
Leu Lys Gly Ile Lys Thr Asn Thr Ala Leu Gln Glu Met Pro Leu Ser
405 410 415
Glu Leu Gln Ala Ala Ala Pro Gln Ile Gln Gln Asp Val Tyr Ala Glu
420 425 430
Leu Thr Ser Lys Ala Ala Val Asp Arg Arg Thr Ser Leu Gly Gly Thr
435 440 445
Ala Val Ser Asn Val Leu Lys Glu Val Ala Arg Asp Glu Glu Met Ile
450 455 460
Ala Ser His
465
<210> 2
<211> 467
<212> PRT
<213> 人工序列
<400> 2
Met Gly Thr Ala Gly Met His Met Thr Asp Lys Leu Trp Gly Gly Arg
1 5 10 15
Phe Thr Glu Lys Ala Ala His Trp Val Asp Ala Phe Gly Ala Ser Ile
20 25 30
Gly Phe Asp Gln Gln Met Ala Gln Glu Asp Leu Glu Gly Ser Leu Ala
35 40 45
His Val Lys Met Leu Gly Lys Thr Gly Ile Ile Pro Gln Ala Asp Ala
50 55 60
Asp Thr Ile Thr Ala Gly Leu Gln His Leu Gln Lys Glu Leu Ala Ala
65 70 75 80
Gly Lys Leu His Phe Thr Val Glu Asn Glu Asp Ile His Leu Asn Met
85 90 95
Glu Ala Leu Leu Thr Ala Glu Ile Gly Pro Val Ala Gly Lys Leu His
100 105 110
Thr Ala Arg Ser Arg Asn Asp Gln Val Ala Thr Asp Leu His Leu Trp
115 120 125
Leu Lys His Arg Leu Pro Thr Ile Lys Glu Ala Leu Thr Asn Leu Gln
130 135 140
Thr Val Leu Val Gly Gln Ala Lys Val His Ala Ala Thr Ile Met Pro
145 150 155 160
Gly Tyr Thr His Met Gln His Ala Gln Pro Ile Thr Tyr Gly His Tyr
165 170 175
Leu Leu Ala Tyr Phe Glu Met Phe Gln Arg Asp Trp Glu Arg Phe Asp
180 185 190
Phe Thr Gln Lys His Thr Asp Ile Leu Pro Leu Gly Ala Ala Ala Leu
195 200 205
Ala Gly Thr Thr Phe Pro Ile Asp Arg Thr Leu Val Ala Gln Glu Leu
210 215 220
Gly Phe Asp Gln Ile Tyr His Asn Ser Leu Asp Ala Val Ser Asp Arg
225 230 235 240
Asp Phe Ala Leu Glu Phe Leu Ser Asn Ser Ala Ile Leu Met Gln His
245 250 255
Leu Ser Arg Met Ala Glu Glu Leu Ile Leu Trp Ser Thr Tyr Glu Phe
260 265 270
Asn Tyr Ile Glu Leu Gly Asp Asp Phe Ser Thr Gly Ser Ser Ile Met
275 280 285
Pro Gln Lys Lys Asn Pro Asp Phe Ala Glu Leu Ile Arg Gly Lys Thr
290 295 300
Gly Arg Val Tyr Gly Ala Leu Met Gly Leu Leu Thr Thr Met Lys Ala
305 310 315 320
Ile Pro Leu Ala Tyr Asn Lys Asp Met Gln Glu Asp Lys Glu Pro Ile
325 330 335
Phe Asp Ala Tyr Asn Thr Ile Leu Gly Ser Leu His Ile Phe Thr Gly
340 345 350
Met Leu Ser Asp Leu Thr Val His Glu Lys Arg Met Ala Glu Ala Thr
355 360 365
Thr His Asp Phe Ser Asn Ala Thr Glu Leu Ala Asp Tyr Leu Ala Thr
370 375 380
Lys Gly Val Pro Phe Arg Gln Ala His Ala Ile Val Gly Glu Leu Val
385 390 395 400
Leu Lys Gly Ile Lys Thr Asn Thr Ala Leu Gln Glu Met Pro Leu Ser
405 410 415
Glu Leu Gln Ala Ala Ala Pro Gln Ile Gln Gln Asp Val Tyr Ala Glu
420 425 430
Leu Thr Ser Lys Ala Ala Val Asp Arg Arg Thr Ser Leu Gly Gly Thr
435 440 445
Ala Val Ser Asn Val Leu Lys Glu Val Ala Arg Asp Glu Glu Met Ile
450 455 460
Ala Ser His
465